Cargando…

Targeting protein kinase CK2 in the treatment of cholangiocarcinoma

Cholangiocarcinoma (CCA) is a disease with a very poor prognosis and limited treatment options. Although targeted therapies directed towards specific mutations found in CCA are becoming available and are showing great potential, many tumors do not carry actionable mutations and, in those that do, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jayaraman, Padma-Sheela, Gaston, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Open Exploration 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400764/ https://www.ncbi.nlm.nih.gov/pubmed/36045705 http://dx.doi.org/10.37349/etat.2021.00055

Ejemplares similares

Protein kinase CK2 inactivates PRH/Hhex using multiple mechanisms to de-repress VEGF-signalling genes and promote cell survival
por: Noy, Peter, et al.
Publicado: (2012)

CX-4945 Induces Methuosis in Cholangiocarcinoma Cell Lines by a CK2-Independent Mechanism
por: Lertsuwan, Jomnarong, et al.
Publicado: (2018)

CK2 phosphorylation of the PRH/Hex homeodomain functions as a reversible switch for DNA binding
por: Soufi, Abdenour, et al.
Publicado: (2009)

Correction: Lertsuwan et al. CX-4945 Induces Methuosis in Cholangiocarcinoma Cell Lines by a CK2-Independent Mechanism. Cancers 2018, 10, 283
por: Lertsuwan, Jomnarong, et al.
Publicado: (2022)

The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells
por: Di Maira, Giovanni, et al.
Publicado: (2019)

Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2
por: Spinello, Zaira, et al.
Publicado: (2021)

Misregulation of the proline rich homeodomain (PRH/HHEX) protein in cancer cells and its consequences for tumour growth and invasion
por: Gaston, Kevin, et al.
Publicado: (2016)

CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders
por: Baier, Andrea, et al.
Publicado: (2022)

Protein Kinase CK2, a Potential Therapeutic Target in Carcinoma Management
por: Lian, Haiwei, et al.
Publicado: (2019)

Protein Kinase CK2—A Putative Target for the Therapy of Diabetes Mellitus?
por: Ampofo, Emmanuel, et al.
Publicado: (2019)

The Multiple Personalities of the Regulatory Subunit of Protein Kinase CK2: CK2 Dependent and CK2 Independent Roles Reveal a Secret Identity for CK2β
por: Bibby, Ashley C., et al.
Publicado: (2005)

Protein kinase CK2 and ion channels (Review)
por: Montenarh, Mathias, et al.
Publicado: (2020)

Protein Kinase CK2 and Epstein–Barr Virus
por: Montenarh, Mathias, et al.
Publicado: (2023)

The Proline Rich Homeodomain Protein PRH/Hhex Forms Stable Oligomers That Are Highly Resistant to Denaturation
por: Shukla, Anshuman, et al.
Publicado: (2012)

Protein kinase CK2 inhibition suppresses neointima formation via a proline-rich homeodomain-dependent mechanism
por: Wadey, K.S., et al.
Publicado: (2017)

Dasatinib inhibits leukaemic cell survival by decreasing PRH/Hhex phosphorylation resulting in increased repression of VEGF signalling genes
por: Noy, Peter, et al.
Publicado: (2012)

The Link between Protein Kinase CK2 and Atypical Kinase Rio1
por: Kubiński, Konrad, et al.
Publicado: (2017)

Role of protein kinase CK2 in antitumor drug resistance
por: Borgo, Christian, et al.
Publicado: (2019)

Protein kinase CK2: a potential therapeutic target for diverse human diseases
por: Borgo, Christian, et al.
Publicado: (2021)

Protein Kinase CK2 and Its Potential Role as a Therapeutic Target in Huntington’s Disease
por: White, Angel, et al.
Publicado: (2022)

The Immune Regulatory Role of Protein Kinase CK2 and Its Implications for Treatment of Cancer
por: Hong, Huixian, et al.
Publicado: (2021)

Protein Kinase CK2 in Cancer Energetics
por: Silva-Pavez, Eduardo, et al.
Publicado: (2020)

The PRH/Hex repressor protein causes nuclear retention of Groucho/TLE co-repressors
por: Desjobert, Cecile, et al.
Publicado: (2008)

Role of Protein Kinase CK2 in Aberrant Lipid Metabolism in Cancer
por: Guerra, Barbara, et al.
Publicado: (2020)

Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias
por: Morotti, Alessandro, et al.
Publicado: (2015)

Targeting Casein Kinase 1 (CK1) in Hematological Cancers
por: Janovská, Pavlína, et al.
Publicado: (2020)

Malaria Protein Kinase CK2 (PfCK2) Shows Novel Mechanisms of Regulation
por: Graciotti, Michele, et al.
Publicado: (2014)

Role of protein kinases CK1α and CK2 in multiple myeloma: regulation of pivotal survival and stress-managing pathways
por: Manni, Sabrina, et al.
Publicado: (2017)

The New Role for an Old Kinase: Protein Kinase CK2 Regulates Metal Ion Transport
por: Johnson, Adam J., et al.
Publicado: (2016)

Protein Kinase CK2: Intricate Relationships within Regulatory Cellular Networks
por: Nuñez de Villavicencio-Diaz, Teresa, et al.
Publicado: (2017)

Casein Kinase 2 (CK2): A Possible Therapeutic Target in Acute Myeloid Leukemia
por: Bruserud, Øystein, et al.
Publicado: (2023)

Targeting of Protein Kinase CK2 Elicits Antiviral Activity on Bovine Coronavirus Infection
por: Ramón, Ailyn C., et al.
Publicado: (2022)

The Role of Protein Kinase CK2 in Development and Disease Progression: A Critical Review
por: Halloran, Daniel, et al.
Publicado: (2022)

A molecular and cellular view of protein kinase CK2 /
Publicado: (1999)

Protein kinase CK2 opens the gate for zinc signaling
por: Taylor, Kathryn M., et al.
Publicado: (2012)

Regulation of the Epithelial Na(+) Channel by the Protein Kinase CK2
por: Bachhuber, Tanja, et al.
Publicado: (2008)

Antitumoral activity of allosteric inhibitors of protein kinase CK2
por: Moucadel, Virginie, et al.
Publicado: (2011)

Copper Modulates the Catalytic Activity of Protein Kinase CK2
por: Chojnowski, John E., et al.
Publicado: (2022)

Emerging role of Protein Kinase CK2 in Tumor immunity
por: Chen, Leichong, et al.
Publicado: (2022)

PRH/Hex: an oligomeric transcription factor and multifunctional regulator of cell fate
por: Soufi, Abdenour, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_vbhu0gkinhrijlfk690qhl6r8n